These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 10617899)

  • 1. Progress in active specific immunotherapy of prostate cancer.
    Tjoa BA; Murphy GP
    Semin Surg Oncol; 2000; 18(1):80-7. PubMed ID: 10617899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of dendritic-cell based prostate cancer vaccine.
    Tjoa BA; Murphy GP
    Immunol Lett; 2000 Sep; 74(1):87-93. PubMed ID: 10996633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunotherapy for Prostate Cancer: Where Do We Go From Here?-PART 1: Prostate Cancer Vaccines.
    Patel A; Fong L
    Oncology (Williston Park); 2018 Mar; 32(3):112-20. PubMed ID: 29548065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunotherapeutics in development for prostate cancer.
    Harzstark AL; Small EJ
    Oncologist; 2009 Apr; 14(4):391-8. PubMed ID: 19342474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in specific immunotherapy for prostate cancer.
    Kiessling A; Füssel S; Wehner R; Bachmann M; Wirth MP; Rieber EP; Schmitz M
    Eur Urol; 2008 Apr; 53(4):694-708. PubMed ID: 18061335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate cancer vaccines: current status and future potential.
    Doehn C; Böhmer T; Kausch I; Sommerauer M; Jocham D
    BioDrugs; 2008; 22(2):71-84. PubMed ID: 18345705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in prostate cancer immunotherapy.
    Havranek EG; Whelan MA; Greenhalgh R; Dalgleish AG; Pandha H
    Surg Oncol; 2002 Jun; 11(1-2):35-45. PubMed ID: 12031866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic prostate cancer vaccines: a review of the latest developments.
    Mohebtash M; Madan RA; Gulley JL; Arlen PM
    Curr Opin Investig Drugs; 2008 Dec; 9(12):1296-301. PubMed ID: 19037836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunotherapy of metastasis.
    Dallal RM; Lotze MT
    Surg Oncol Clin N Am; 2001 Apr; 10(2):433-47, xi. PubMed ID: 11382596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current immunotherapeutic strategies in prostate cancer.
    Grosso JF; Drake CG
    Surg Oncol Clin N Am; 2007 Oct; 16(4):861-71, x. PubMed ID: 18022549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual antigen target-based immunotherapy for prostate cancer eliminates the growth of established tumors in mice.
    Karan D; Dubey S; Van Veldhuizen P; Holzbeierlein JM; Tawfik O; Thrasher JB
    Immunotherapy; 2011 Jun; 3(6):735-46. PubMed ID: 21668311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapy for prostate cancer.
    Fong L; Small EJ
    Semin Oncol; 2003 Oct; 30(5):649-58. PubMed ID: 14571412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunotherapy for prostate cancer: walk, don't run.
    Drake CG
    J Clin Oncol; 2009 Sep; 27(25):4035-7. PubMed ID: 19635998
    [No Abstract]   [Full Text] [Related]  

  • 14. [Active immunotherapy of prostate cancer with a focus on dendritic cells].
    Thomas-Kaskel AK; Veelken H
    Actas Urol Esp; 2007 Jun; 31(6):668-79. PubMed ID: 17896564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccines as treatment strategies for relapsed prostate cancer: approaches for induction of immunity.
    Slovin SF
    Hematol Oncol Clin North Am; 2001 Jun; 15(3):477-96. PubMed ID: 11525292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate cancer: advances in immunotherapy.
    Hurwitz AA; Yanover P; Markowitz M; Allison JP; Kwon ED
    BioDrugs; 2003; 17(2):131-8. PubMed ID: 12641491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dendritic cell based vaccines: progress in immunotherapy studies for prostate cancer.
    Ragde H; Cavanagh WA; Tjoa BA
    J Urol; 2004 Dec; 172(6 Pt 2):2532-8. PubMed ID: 15538202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotherapeutic approaches in prostate cancer: combinations and clinical integration.
    Slovin SF
    Am Soc Clin Oncol Educ Book; 2015; ():e275-83. PubMed ID: 25993186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dendritic cell immunotherapy for urological cancers using cryopreserved allogeneic tumour lysate-pulsed cells: a phase I/II study.
    Pandha HS; John RJ; Hutchinson J; James N; Whelan M; Corbishley C; Dalgleish AG
    BJU Int; 2004 Aug; 94(3):412-8. PubMed ID: 15291878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccines for immunotherapy of breast cancer and prostate cancer: new developments and comparative aspects.
    Minev BR; Guo F; Gueorguieva I; Kaiser HE
    In Vivo; 2002; 16(6):405-15. PubMed ID: 12494883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.